Thursday 22 September 2022

Shilpa medicare bags CDSCO approval for Tranexamic Acid Spray

Shilpa medicare bags CDSCO approval for Tranexamic Acid Spray
Shilpa medicare bags CDSCO approval for Tranexamic Acid Spray

Shilpa medicare gets CDSCO approval for Tranexamic Acid Spray, Hemostatic Spray. The product is protected by granted patents in India till 2037 and in US, Australia, Russia and South Africa till 2038. Shilpa is continuously pursuing patent prosecution in other countries and for further protection.

Rajesh Vagh Thu, 09/22/2022 - 16:50

source https://www.pharmatutor.org/pharma-news/2022/shilpa-medicare-bags-cdsco-approval-for-tranexamic-acid-spray

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...